Welcome to the Waldenstrom’s Macroglobulinemia Foundation of Canada (WMFC)

If you have been diagnosed with Waldenstrom’s Macroglobulinemia (WM) or care for someone who has, welcome to the WMFC family of WM patients, caregivers, friends and relatives. We are a community providing support, research and information on WM.

Sign up for our newsletter below to receive updated information.

Information for the newly diagnosed

BTK Inhibitors Transform Waldenström Macroglobulinemia Management

October 6, 2020  September 29, 2020 Erica DiNapoli https://www.onclive.com/view/btk-inhibitors-transform-waldenstr-m-macroglobulinemia-management   BTK inhibitors have transformed the treatment of patients with Waldenström macroglobulinemia, according to Steven P. Treon, MD, PhD, who added that with Read More

BeiGene Announces Acceptance and Priority Review by Health Canada of New Drug Submission for BRUKINSA® (zanubrutinib) in Waldenström’s Macroglobulinemia

September 10, 2020CAMBRIDGE, Mass. & BEIJING–(BUSINESS WIRE)–BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that its New Drug Submission (NDS) Read More

Watchful Waiting Urged for Indolent Lymphoma During COVID-19

September 10, 2020Read Article

• 1
• 2
• 3

We have been compiling a list of websites that contain useful information about WM and also some information about the COVID-19 virus.